ArticleFrontiers in oncology2021

Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation.

Rossella Bruno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.